DYNATROPE (SOMATROPINA) HUMAN GROWTH HORMONE INJECTION
DYNATROPE SOMATROPINA RECOMBINANT HUMAN GROWTH HORMONE INJECTION
DYNATROPE (SOMATROPINA) HUMAN GROWTH HORMONE INJECTION
Dynatrope Somatropina
Buy dynatrope somatropina online
COMPOSITION
Active ingredient: Somatotropin 4 IU (1,33 mg) / 10 IU (3,33 mg)
16 IU (5,33 mg) / 20 IU (6,67 mg)
Inactive ingredients: mannitol, glycine, sodium dihydrogen phosphate, sodium
chloride.
Solvent: water for injections.
BUY DYNATROPE SOMATROPINA RECOMBINANT HUMAN GROWTH HORMONE INJECTION
INDICATIONS
Growth inhibition due to insufficient secretion of growth hormone, gonadal
digenesis (Turner’s syndrome), chronic renal insufficiency in prepubertal
period.Buy dynatrope somatropina online
Replacement therapy in adults with confirmed inheritable or nonheritable growth
hormone deficiency.
DOSAGE AND ADMINISTRATION OF Dynatrope somatropina 10iu x 25 vials
Dynatrope somatropina 10iu x 25 vials is injected subcutaneously, slowly, 1
time a day, usually before going to bed. To prevent lipoatrophy, sites of
injections should be changed.Buy dynatrope somatropina online
BUY DYNATROPE SOMATROPINA HUMAN GROWTH HORMONE INJECTION
Vial content need to be dissolved in 1 ml of enclosed solvent, on the basis of
calculated dose. In this purpose the solvent is taken to the syringe and
brought into the vial with lyophilizate through the stopper. Carefully shake
until content of vial is fully dissolved. Sharp shaking is impermissible. Ready
solution can be stored during two weeks at temperature of 2-8 degrees
Celsius.Buy dynatrope somatropina online
BUY DYNATROPE RECOMBINANT HUMAN GROWTH HORMONE INJECTION
The dosage is individual, based on level of growth hormone deficiency, body
weight or body surface area and efficiency of treatment.
In children with growth hormone deficiency recommended dose is 25-35 µg/kg/day,
which is equivalent to 0,7-1 mg/m2/day (2-3 IU/m2/day). Treatment must be
initiated as early as possible in the younger age and continued until sexual
maturation begins or until bones growth plates close. Treatment may be finished
when desirable result obtained.
Turner’s syndrome, chronic kidney disease in children, which is accompanied
with growth inhibition: recommended dose is 50µg/kg/day, which is equivalent to
1,4 mg/m2/day (4,3 IU/m2/day). Insufficient growth dynamics may require dose
correction.
BUY DYNATROPE HUMAN GROWTH HORMONE INJECTION
Growth hormone deficiency in adult: initial dose is 0,15-0,3mg/day (which is
equivalent to 0,45-0,9 IU/day) with following increase, depending on result
obtained. Level of insulin-like growth factor I (IGF-1) in serum may be used as
control value for dose titration. Maintaining dose is individual, but it is not
higher than, generally, 1 mg/day, which is equivalent to 3 IU/day. Lower
dosages are recommended for use in elderly.
PHARMACEUTICAL FORM
Lyophilizate for solution for subcutaneous injections 4 IU, 10 IU.
Lyophilizate: 4 IU and 10 IU in glass vial.
Solvent: 1 ml in ampoule of neutral glass.
25 vials with lyophilizate c/w 10 ampoules with solvent in cardboard pack with
application data sheet.
BUY DYNATROPE SOMATROPINA HGH INJECTION
BUY DYNATROPE SOMATROPINA RHGH INJECTION
BUY DYNATROPE HGH INJECTION
BUY DYNATROPE RHGH INJECTION
STORAGE
Store in shadowed place at temperature from 2 to 8 degrees Celsius.
Do not freeze.
Reconstituted solution may be kept during 2 weeks at temperature from 2 to 8
degrees Celsius.
Keep out of reach of children.
BUYERS MUST PLACE ALL YOUR ORDERS ON THE EMAIL ADDRESS OR TELEGRAM ID AS BELOW:
TELEGRAM: Greenlida
EMAIL ADDRESS: beautycaremedsphamltd2020(AT)gmail.com
Other supplier products
All supplier products
Same products
